Skip over navigation
Pfizer has launched Quillivant XR (controlled-release methylphenidate hydrochloride) for the treatment of ADHD. This is the first once-daily, extended-release liquid methylphenidate for ADHD available in the U.S.
Sponsored Links
About these ads
Consumer Tips
©2010 WETA. All Rights Reserved. | Privacy Policy | Terms & Conditions | Site Index | Home
About LD OnLine | Contact Us |
LD Basics | ADHD Basics | Questions + Answers | Glossary | LD Topics
For Educators | For Parents | For Kids | Expert Advice | LD Resources | Yellow Pages | LearningStore
IDEA 2004 | Contributors | First Person | Newsletters | Calendar | En Español | Forums | How to Advertise
LD OnLine works in association with the National Joint Committee on Learning Disabilities (NJCLD). Learn more.
LD OnLine is an educational service of public television station WETA in Washington, D.C.
Visit WETA's educational web sites:
LD OnLine® is a registered trademark of WETA.
Stay informed! Subscribe to our e-mail newsletter.
